Formalin Test

The formalin test is a well-established tonic pain assay based on a chemical stimulus. Unilateral subcutaneous injection of formalin into the hindpaw produces a biphasic nocifensive response: an early phase (0-10 min), driven by direct activation of primary afferent sensory neurons, followed by a late phase (15-60 min) reflecting the combined effects of ongoing afferent input, spinal central sensitization, and local inflammatory processes.

This temporal dissociation gives the model strong mechanistic resolution: centrally acting analgesics (e.g., opioids) and NSAIDs preferentially suppress the late phase, while agents acting on acute nociceptive transduction act on the early phase, allowing early characterization of a candidate’s site and mode of action.

Nocifensive behaviors (licking, biting, paw flinching/lifting) are scored across both phases to quantify analgesic efficacy, making the formalin test a robust, high-throughput screening tool for compounds intended for persistent pain states involving tissue injury.